GL1X · GenesisL1 explorer

MolNFT v1 · #102682 · protein

Crystal structure of btk kinase domain complexed with 4-tert-butyl-N- (3-{8-[4-(4-methyl-piperazine-1-carbonyl)-phenylamino]-IMIDAZO[1,2- A]PYRAZIN-6-yl}-phenyl)-benzamide

4OT5 · Tyrosine-protein kinase btk: “Crystal structure of btk kinase domain complexed with 4-tert-butyl-N…”. X-ray diffraction, 1 ligand (481), 1 pocket (best druggability 0.71). MolNFT v1 #102682 on GenesisL1: 3D structure, binding sites…

PDB
4OT5
Type
protein
Length
263 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein kinase btk
EC
2.7.10.2
UniProt
Q06187
Ligands
481
Pockets
1 · best druggability 0.71

Structure

x-ray diffraction · 1 distinct chain · 43% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein kinase btk (EC 2.7.10.2)protein26343% helix, 17% strandQ06187

Ligands and binding sites

  • 481 · 4-tert-butyl-N-{3-[8-({4-[(4-methylpiperazin-1-yl)carbonyl]phenyl}amino)imidazo[1,2-a]pyrazin-6-yl]phenyl}benzamide · ligand · chains A
  • DMS · Dimethyl sulfoxide · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14310.710.8254481

Compared structures

  • 4OT5 · Crystal structure of BTK kinase domain complexed with… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q06187 · AlphaFold monomer V2.0 prediction for tyrosine-protein kinase btk (Q06187) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.